Otitis treatment made simple using EasOtic®
One bottle provides a full treatment course for all sizes of dog, with no wastage. With just one pump in each ear, once a day for 5 days this fast acting HCA will reduce inflammation with minimal systemic absorption
With an excellent safety profile which is documented in numerous studies this first-line use gentamicin is broad - spectrum with minimal risk of resistance1
Product Features & Benefits:
Flexible nozel - Reaches the affected area using a gentle, atraumatic nozzle
Airless bottle - Prevents retro-contamination and delivers accurate dosing at any angle, even upside down!
Easy dosing - Exact 1ml dose in 1 press, once a day for only 5 days
Potent steroid - HCA is fast acting to reduce inflammation with minimal systemic absorption. The same steroid as Cortavance!
Long acting - Gentamicin and miconazole are active in the ear for 15 days above MIC90
How Important Is an Ear Cleaner in the Short and Long-Term Management of Otitis Externa in Dogs?
Otitis externa is a very common condition in dogs, yet can be difficult to manage, successfully, in practice. Once the patient has been examined and a diagnosis has been established, the choice of treatment prescribed will be the key to success in treating otitis externa.
Easotic is a veterinary medicine used to treat dogs that suffer from acute or recurrent episodes of ear infections (otitis externa). It contains three active substances: hydrocortisone aceponate, miconazole nitrate and gentamicin sulphate.
The product is applied using the integral pump which delivers a measured dose of 1ml per pump. The dose rate is 1 pump per day for 5 consecutive days.
Yes, the product has proven efficacy with the unique combination of active ingredients achieving control and resolution of infection and inflammation after the 5 days of application.
Gentamicin is a concentration dependent aminoglycoside antibiotic and when used topically has a broad spectrum of activity that meets the requirements for responsible first line use. This is different to IV use where much lower dose rates must be used to protect the kidneys and the resultant spectrum of activity is narrow and restricted to gram negative bacteria.